The Ministry of Food and Drug Safety held the 6th Cosmetics Day celebration with the Korea Cosmetics Association today (17th).Under the slogan "K-Cosmetics, ...
today announced that the U.S. Foodand DrugAdministration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.